Back to search
FDAFDA · Food and drugs·Recall number D-300-2013

Pentrexcilina Jarabe NF (dextromethorphan HBr and guaifenesin) liquid, 118 mL/ 4 fl oz bottle, Distributed by Laboratorios Nordimex Co., San Diego, CA 92154, UPC 0 91965 02001 1.

Published May 1, 2013 · Recall initiated: April 12, 2013

Summary

FDA records drug Class II recall D-300-2013, published May 1, 2013 and initiated April 12, 2013. Recalling firm: OPMX, LLC; Status: Terminated; Reported quantity: 7,610 bottles; Lot: Lot #: 11649A0, Exp 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
OPMX, LLC
Distributor
Nationwide
Lot
Lot #: 11649A0, Exp 12/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pentrexcilina Jarabe NF (dextromethorphan HBr and guaifenesin) liquid, 118 mL/ 4 fl oz bottle, Distributed by Laboratorios Nordimex Co., San Diego, CA 92154, UPC 0 91965 02001 1. recalled?

Yes. FDA published recall D-300-2013 on May 1, 2013. Reported hazard: Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.

What should I do if I have this product?

Voluntary: Firm initiated · Letter